Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Fine

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|July 25, 1992
Controlling leprosyC Lienhardt, P E Fine
Epidemiology and Infection|November 18, 1997
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfectionE Vynnycky, P E Fine
Leprosy Review|March 1, 1994
Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?C Lienhardt, P E Fine
Vaccine|October 31, 1998
The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccinesP E Fine, E Vynnycky
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|May 29, 1999
Report of workshop on epidemiology/transmission/vaccinesP E Fine, R Truman
American Journal of Epidemiology|December 1, 1986
Individual versus public priorities in the determination of optimal vaccination policiesP E Fine, J A Clarkson
International Journal of Epidemiology|September 1, 1983
Measles in England and Wales--III: Assessing published predictions of the impact of vaccination on incidenceP E Fine, J A Clarkson
Health Trends|January 10, 1987
Delays in notification of infectious diseaseJ A Clarkson, P E Fine
Lancet (London, England)|April 28, 1990
Modern vaccines. Mycobacterial diseasesP E Fine, L C Rodrigues
International Journal of Epidemiology|March 1, 1982
Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the populationP E Fine, J A Clarkson
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|July 25, 1992
Controlling leprosyC Lienhardt, P E Fine
Epidemiology and Infection|November 18, 1997
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfectionE Vynnycky, P E Fine
Leprosy Review|March 1, 1994
Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?C Lienhardt, P E Fine
Vaccine|October 31, 1998
The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccinesP E Fine, E Vynnycky
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|May 29, 1999
Report of workshop on epidemiology/transmission/vaccinesP E Fine, R Truman
American Journal of Epidemiology|December 1, 1986
Individual versus public priorities in the determination of optimal vaccination policiesP E Fine, J A Clarkson
International Journal of Epidemiology|September 1, 1983
Measles in England and Wales--III: Assessing published predictions of the impact of vaccination on incidenceP E Fine, J A Clarkson
Health Trends|January 10, 1987
Delays in notification of infectious diseaseJ A Clarkson, P E Fine
Lancet (London, England)|April 28, 1990
Modern vaccines. Mycobacterial diseasesP E Fine, L C Rodrigues
International Journal of Epidemiology|March 1, 1982
Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the populationP E Fine, J A Clarkson
Pageof 14